Q2 2024 · 13F-HR
TANG CAPITAL MANAGEMENT LLCholdings as filed
Filed 2024-08-14 · accession 0001214659-24-014706
$981.9M
Reported value
128
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $61.3M | 6.24% | 2,254,797 | Common | SHARED |
| 30052C107 | EOLS | EVOLUS INC | $52.6M | 5.36% | 4,847,399 | Common | SHARED |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $49.7M | 5.06% | 4,218,829 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $44.0M | 4.48% | 1,287,107 | Common | SHARED |
| 032724106 | ANAB | ANAPTYSBIO INC | $33.4M | 3.40% | 1,330,879 | Common | SHARED |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $28.7M | 2.92% | 450,000 | Common | SHARED |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $28.1M | 2.86% | 2,500,000 | Common | SHARED |
| 532457108 | LLY | ELI LILLY & CO | $24.4M | 2.49% | 27,000 | Common | SHARED |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $24.4M | 2.48% | 1,500,000 | Common | SHARED |
| 92243G108 | PCVX | VAXCYTE INC | $22.7M | 2.31% | 300,000 | Common | SHARED |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $21.4M | 2.18% | 700,000 | Common | SHARED |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $20.5M | 2.09% | 300,000 | Common | SHARED |
| 02155H200 | ALT | ALTIMMUNE INC | $18.3M | 1.86% | 2,750,000 | Common | SHARED |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $18.1M | 1.85% | 1,392,925 | Common | SHARED |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $17.3M | 1.76% | 1,230,000 | Common | SHARED |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $17.1M | 1.74% | 316,500 | Common | SHARED |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $16.1M | 1.64% | 750,000 | Common | SHARED |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $16.1M | 1.64% | 921,138 | Common | SHARED |
| 05156V102 | AUPH | AURINIA PHARMACEUTICALS INC | $15.9M | 1.62% | 2,779,500 | Common | SHARED |
| 37733W204 | GSK | GSK PLC | $15.4M | 1.57% | 400,000 | Common | SHARED |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $14.9M | 1.52% | 140,000 | Common | SHARED |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $14.8M | 1.51% | 4,476,741 | Common | SHARED |
| 67066G104 | NVDA | NVIDIA CORPORATION | $14.2M | 1.45% | 115,019 | Common | SHARED |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $13.7M | 1.40% | 405,600 | Common | SHARED |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $12.9M | 1.32% | 747,616 | Common | SHARED |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $12.2M | 1.24% | 2,153,307 | Common | SHARED |
| 69012T305 | OTLK | OUTLOOK THERAPEUTICS INC | $12.0M | 1.22% | 1,619,412 | Common | SHARED |
| 046353108 | AZNN | ASTRAZENECA PLC | $11.7M | 1.19% | 150,000 | Common | SHARED |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $11.7M | 1.19% | 625,309 | Common | SHARED |
| 67080N101 | NUVB | NUVATION BIO INC | $11.0M | 1.12% | 3,751,864 | Common | SHARED |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $10.9M | 1.11% | 2,330,000 | Common | SHARED |
| 007002108 | TORCEUR | ADICET BIO INC | $9.9M | 1.01% | 8,216,960 | Common | SHARED |
| 87918A105 | TDOC | TELADOC HEALTH INC | $9.8M | 1.00% | 1,000,000 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $9.5M | 0.97% | 7,791,936 | Common | SHARED |
| 14179K101 | CRGX | CARGO THERAPEUTICS INC | $9.4M | 0.96% | 572,697 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $9.4M | 0.95% | 1,100,000 | Common | SHARED |
| 45257U108 | IMNM | IMMUNOME INC | $8.7M | 0.89% | 720,000 | Common | SHARED |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $8.5M | 0.86% | 281,200 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $8.3M | 0.84% | 3,060,000 | Common | SHARED |
| 09062X103 | BIIB | BIOGEN INC | $8.1M | 0.83% | 35,000 | Common | SHARED |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $7.5M | 0.76% | 1,603,200 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $7.2M | 0.74% | 805,440 | Common | SHARED |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $7.2M | 0.73% | 3,100,000 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $7.1M | 0.73% | 150,000 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $6.9M | 0.70% | 264,692 | Common | SHARED |
| 457669307 | INSM | INSMED INC | $6.7M | 0.68% | 100,000 | Common | SHARED |
| 427746102 | HRTX | HERON THERAPEUTICS INC | $6.5M | 0.66% | 1,850,000 | Common | SHARED |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $6.4M | 0.65% | 120,000 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $6.3M | 0.64% | 270,000 | Common | SHARED |
| 74019P207 | DTIL | PRECISION BIOSCIENCES INC | $6.1M | 0.62% | 623,332 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $5.9M | 0.60% | 100,000 | Common | SHARED |
| 30303M102 | META | META PLATFORMS INC | $5.7M | 0.59% | 11,396 | Common | SHARED |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $5.7M | 0.58% | 144,500 | Common | SHARED |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $5.6M | 0.57% | 4,800,000 | Common | SHARED |
| 23282W605 | CYTK | CYTOKINETICS INC | $5.4M | 0.55% | 100,000 | Common | SHARED |
| 07725L102 | ONC | BEIGENE LTD | $5.3M | 0.54% | 37,000 | Common | SHARED |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $5.0M | 0.51% | 1,480,975 | Common | SHARED |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $4.9M | 0.50% | 800,000 | Common | SHARED |
| G1110E107 | BHVN | BIOHAVEN LTD | $4.9M | 0.49% | 140,000 | Common | SHARED |
| 04335A105 | ARVN | ARVINAS INC | $4.8M | 0.49% | 180,000 | Common | SHARED |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $4.7M | 0.48% | 40,000 | Common | SHARED |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $4.5M | 0.46% | 2,996,260 | Common | SHARED |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $4.2M | 0.43% | 350,000 | Common | SHARED |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $4.0M | 0.41% | 50,000 | Common | SHARED |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.0M | 0.41% | 500,000 | Common | SHARED |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.9M | 0.40% | 100,000 | Common | SHARED |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $3.9M | 0.40% | 300,000 | Common | SHARED |
| 81578P106 | SEER | SEER INC | $3.9M | 0.39% | 2,300,000 | Common | SHARED |
| 65487U108 | NKTX | NKARTA INC | $3.3M | 0.33% | 550,000 | Common | SHARED |
| 097702104 | BOLT1EUR | BOLT BIOTHERAPEUTICS INC | $2.9M | 0.29% | 3,812,773 | Common | SHARED |
| 604749AB7 | MIRM 4 05/01/29 | MIRUM PHARMACEUTICALS INC | $2.8M | 0.29% | 2,120,000 | Common | SHARED |
| 04746L104 | — | ATHIRA PHARMA INC | $2.8M | 0.28% | 1,052,715 | Common | SHARED |
| 372303206 | GMAB | GENMAB A/S | $2.5M | 0.26% | 100,000 | Common | SHARED |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $2.4M | 0.24% | 167,500 | Common | SHARED |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $2.3M | 0.23% | 700,000 | Common | SHARED |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $2.3M | 0.23% | 900,000 | Common | SHARED |
| 25960P109 | DEI | DOUGLAS EMMETT INC | $2.3M | 0.23% | 171,138 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $2.1M | 0.21% | 100,000 | Common | SHARED |
| 09077B104 | BCABGBP | BIOATLA INC | $1.9M | 0.19% | 1,374,076 | Common | SHARED |
| 19249H103 | CHRS | COHERUS BIOSCIENCES INC | $1.8M | 0.19% | 1,050,000 | Common | SHARED |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $1.8M | 0.18% | 100,000 | Common | SHARED |
| 81750R102 | MCRB1EUR | SERES THERAPEUTICS INC | $1.7M | 0.18% | 2,407,112 | Common | SHARED |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $1.7M | 0.17% | 1,743,619 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $1.6M | 0.16% | 541,514 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $1.4M | 0.14% | 55,609 | Common | SHARED |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $1.4M | 0.14% | 461,699 | Common | SHARED |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.3M | 0.13% | 79,166 | Common | SHARED |
| 29479A108 | ERAS | ERASCA INC | $1.3M | 0.13% | 550,000 | Common | SHARED |
| 702712100 | — | PASSAGE BIO INC | $1.2M | 0.12% | 1,500,000 | Common | SHARED |
| 68218J103 | OABI | OMNIAB INC | $1.1M | 0.11% | 300,000 | Common | SHARED |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $1.1M | 0.11% | 1,500,000 | Common | SHARED |
| 002120202 | ATYR | ATYR PHARMA INC | $1.0M | 0.11% | 671,134 | Common | SHARED |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $1.0M | 0.10% | 400,000 | Common | SHARED |
| 65343E108 | NXTCEUR | NEXTCURE INC | $958,760 | 0.10% | 602,994 | Common | SHARED |
| 556099109 | MGNX | MACROGENICS INC | $930,138 | 0.09% | 218,856 | Common | SHARED |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $924,000 | 0.09% | 200,000 | Common | SHARED |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $910,000 | 0.09% | 100,000 | Common | SHARED |
| 48115J109 | DERM | JOURNEY MED CORP | $836,536 | 0.09% | 148,322 | Common | SHARED |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $713,622 | 0.07% | 237,874 | Common | SHARED |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $675,146 | 0.07% | 42,223 | Common | SHARED |
| 269796108 | EGRX | EAGLE PHARMACEUTICALS INC | $665,599 | 0.07% | 118,857 | Common | SHARED |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $652,000 | 0.07% | 200,000 | Common | SHARED |
| 046513206 | ATRA | ATARA BIOTHERAPEUTICS INC | $639,166 | 0.07% | 75,196 | Common | SHARED |
| 01626L105 | — | ALIGOS THERAPEUTICS INC | $577,500 | 0.06% | 1,650,000 | Common | SHARED |
| 46625H100 | JPM | JPMORGAN CHASE & CO. | $366,358 | 0.04% | 1,811 | Common | SHARED |
| 594918104 | MSFT | MICROSOFT CORP | $363,637 | 0.04% | 814 | Common | SHARED |
| 931142103 | WMT | WALMART INC | $301,994 | 0.03% | 4,460 | Common | SHARED |
| 084670702 | BRK/B | BERKSHIRE HATHAWAY INC DEL | $289,237 | 0.03% | 711 | Common | SHARED |
| 64110L106 | NFLX | NETFLIX INC | $288,179 | 0.03% | 427 | Common | SHARED |
| 92826C839 | V | VISA INC | $275,338 | 0.03% | 1,049 | Common | SHARED |
| 742718109 | PG | PROCTER AND GAMBLE CO | $254,455 | 0.03% | 1,543 | Common | SHARED |
| 92556V106 | VTRS | VIATRIS INC | $234,707 | 0.02% | 22,080 | Common | SHARED |
| 882508104 | TXN | TEXAS INSTRS INC | $234,122 | 0.02% | 1,204 | Common | SHARED |
| 437076102 | HD | HOME DEPOT INC | $233,582 | 0.02% | 679 | Common | SHARED |
| 025816109 | AXP | AMERICAN EXPRESS CO | $231,667 | 0.02% | 1,001 | Common | SHARED |
| 458140100 | INTC | INTEL CORP | $227,751 | 0.02% | 7,354 | Common | SHARED |
| 191216100 | KO | COCA COLA CO | $226,670 | 0.02% | 3,561 | Common | SHARED |
| 023135106 | AMZN | AMAZON COM INC | $224,895 | 0.02% | 1,164 | Common | SHARED |
| 00534A102 | IVVD | INVIVYD INC | $220,000 | 0.02% | 200,000 | Common | SHARED |
| 369604301 | GE | GE AEROSPACE | $219,840 | 0.02% | 1,383 | Common | SHARED |
| 30231G102 | XOM | EXXON MOBIL CORP | $219,632 | 0.02% | 1,908 | Common | SHARED |
| 92343V104 | VZ | VERIZON COMMUNICATIONS INC | $218,896 | 0.02% | 5,308 | Common | SHARED |
| 254687106 | DIS | DISNEY WALT CO | $201,421 | 0.02% | 2,029 | Common | SHARED |
| 020002101 | ALL | ALLSTATE CORP | $201,229 | 0.02% | 1,260 | Common | SHARED |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $190,000 | 0.02% | 100,000 | Common | SHARED |
| 345370860 | F | FORD MTR CO DEL | $160,177 | 0.02% | 12,773 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $18,075 | 0.00% | 2,500 | Common | SHARED |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $9,196 | 0.00% | 5,109 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.